Search Results - "Shehata, Hatem S."

Refine Results
  1. 1

    The aquaporin4-IgG status and how it affects the clinical features and treatment response in NMOSD patients in Egypt by Kishk, Nirmeen A, Abdelfattah, Walaa, Shalaby, Nevin M, Shehata, Hatem S, Hassan, Amr, Hegazy, Mohamed I, Abokrysha, Noha T, Abdellatif, Doaa, Shawky, Shereen M, Abdo, Sarah S, Taha, Noha, Fouad, Amr M, Elmazny, Alaa, Ragab, Amany H

    Published in BMC neurology (03-02-2021)
    “…In Egypt, the characterization of Neuromyelitis Optica Spectrum Disorder (NMOSD) is lacking. To determine the demographics, clinical features, aquaporin4…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Interleukins 17 and 10 in a sample of Egyptian relapsing remitting multiple sclerosis patients by Tawfik, Tarek Z., MD, Gad, Adel H., MD, Mehaney, Dina A., MD, El Nahrery, Eslam, MD, Shehata, Hatem S., MD, Hashem, Hebatalla, MD, Ghaffar, Nawal F. Abdel, Ms, Shalaby, Nevin Mohieldin, MD

    Published in Journal of the neurological sciences (15-10-2016)
    “…Abstract Background Cytokines are major contributors in the immune disruption in multiple sclerosis (MS). Objective Evaluating the proinflammatory (IL-17A) and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Oromandibular dystonia in yemeni patients with khat chewing: a response to botulinum toxin treatment by Shehata, Hatem S, El-Tamawy, Mohamed S, Mohieldin, Nevin, Edrees, Mohammed, Bohlega, Saeed

    Published in Neurology international (03-06-2014)
    “…Khat-(Catha edulis)related oromandibular dystonia is a difficult-to-treat subset of movement disorders that involve masticatory muscles with diverse and…”
    Get full text
    Journal Article
  6. 6

    Changes in migraine characteristics over 30 days of Ramadan fasting: A prospective study by Ragab, Amany H., Kishk, Nirmeen A., Hassan, Amr, Yacoub, Osama, El Ghoneimy, Lobna, Elmazny, Alaa, Elsawy, Enji H., Mekkawy, Doaa, Othman, Alshimaa S., Rizk, Hoda Ibrahim, Mohammad, Mohammad Edrees, Shehata, Hatem S., Shalaby, Nevin, Magdy, Rehab

    Published in Headache (01-11-2021)
    “…Objective To study Ramadan's effect on migraine from the start to the end of the month and the tolerability of patients with migraine to fasting. Background…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia? by Shehata, Hatem S, El-Tamawy, Mohamed S, Shalaby, Nevin M, Ramzy, Gihan

    Published in Journal of headache and pain (19-11-2013)
    “…Background Botulinum toxin type A (BTX-A) has been reported to have analgesic effects independent of its action on muscle tone, mostly by acting on neurogenic…”
    Get full text
    Journal Article
  10. 10

    Corticobasal degeneration: clinical characteristics and multidisciplinary therapeutic approach in 26 patients by Shehata, Hatem S., Shalaby, Nevin M., Esmail, Eman H., Fahmy, Ebtesam

    Published in Neurological sciences (01-09-2015)
    “…Corticobasal syndrome (CBS) is a sporadic tauopathy that manifests by a various combination of motor and cognitive deficits, which makes its diagnosis…”
    Get full text
    Journal Article
  11. 11

    Prevalence of primary headache disorders in Fayoum Governorate, Egypt by El-Sherbiny, Naglaa A., Masoud, Mohamed, Shalaby, Nevin M., Shehata, Hatem S.

    Published in Journal of headache and pain (05-10-2015)
    “…Background There is abundance of epidemiological studies of headache in developed and western countries; however, data in developing countries and in Egypt are…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Interferon-Beta-Induced Headache in Patients with Multiple Sclerosis: Frequency and Characterization by Elmazny, Alaa, Hamdy, Sherif M, Abdel-Naseer, Maged, Shalaby, Nevin M, Shehata, Hatem S, Kishk, Nirmeen A, Nada, Mona A, Mourad, Husam S, Hegazy, Mohamed I, Abdelalim, Ahmed, Ahmed, Sandra M, Hatem, Ghada, Fouad, Amr M, Mahmoud, Hadel, Hassan, Amr

    Published in Journal of pain research (01-01-2020)
    “…Studies have shown that interferon-beta (IFN-β) treatment is associated with headaches in patients with multiple sclerosis (MS). Headaches can affect quality…”
    Get full text
    Journal Article
  16. 16

    Repetitive transcranial magnetic stimulation versus botulinum toxin injection in chronic migraine prophylaxis: a pilot randomized trial by Shehata, Hatem S, Esmail, Eman H, Abdelalim, Ahmad, El-Jaafary, Shaimaa, Elmazny, Alaa, Sabbah, Asmaa, Shalaby, Nevin M

    Published in Journal of pain research (01-01-2016)
    “…Chronic migraine is a prevalent disabling disease, with major health-related burden and poor quality of life. Long-term use of preventive medications carries…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Evaluating optic nerve diameter as a possible biomarker for disability in patients with multiple sclerosis by Koraysha, Noha Abo, Kishk, Nirmeen, Hassan, Amr, Samy El Gendy, Nehal M, Shehata, Hatem S, Al-Azayem, Salsabil Abo, Kamal, Yasmine Shawki

    Published in Neuropsychiatric disease and treatment (01-01-2019)
    “…The development of new biomarkers for multiple sclerosis (MS) is of paramount importance to improve our ability to predict disease progression and disability…”
    Get full text
    Journal Article